194 related articles for article (PubMed ID: 9038230)
21. Activation and novel processing of matrix metalloproteinases by a thiol-proteinase from the oral anaerobe Porphyromonas gingivalis.
DeCarlo AA; Windsor LJ; Bodden MK; Harber GJ; Birkedal-Hansen B; Birkedal-Hansen H
J Dent Res; 1997 Jun; 76(6):1260-70. PubMed ID: 9168859
[TBL] [Abstract][Full Text] [Related]
22. Characterization and identification of proteinases and proteinase inhibitors synthesized by temporomandibular joint disc cells.
Kapila S; Lee C; Richards DW
J Dent Res; 1995 Jun; 74(6):1328-36. PubMed ID: 7629341
[TBL] [Abstract][Full Text] [Related]
23. Human matrix metalloprotease activation by insults of bacterial infection involving proteases and free radicals.
Maeda H; Okamoto T; Akaike T
Biol Chem; 1998 Feb; 379(2):193-200. PubMed ID: 9524071
[TBL] [Abstract][Full Text] [Related]
24. Furin directly cleaves proMMP-2 in the trans-Golgi network resulting in a nonfunctioning proteinase.
Cao J; Rehemtulla A; Pavlaki M; Kozarekar P; Chiarelli C
J Biol Chem; 2005 Mar; 280(12):10974-80. PubMed ID: 15637056
[TBL] [Abstract][Full Text] [Related]
25. Disruption of the cysteine-75 and zinc ion coordination is not sufficient to activate the precursor of human matrix metalloproteinase 3 (stromelysin 1).
Chen LC; Noelken ME; Nagase H
Biochemistry; 1993 Oct; 32(39):10289-95. PubMed ID: 8399171
[TBL] [Abstract][Full Text] [Related]
26. Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor.
Rao CN; Mohanam S; Puppala A; Rao JS
Biochem Biophys Res Commun; 1999 Feb; 255(1):94-8. PubMed ID: 10082661
[TBL] [Abstract][Full Text] [Related]
27. Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum.
Lark MW; Williams H; Hoernner LA; Weidner J; Ayala JM; Harper CF; Christen A; Olszewski J; Konteatis Z; Webber R
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):245-52. PubMed ID: 7717983
[TBL] [Abstract][Full Text] [Related]
28. Propeptide glycosylation and galectin-3 binding decrease proteolytic activation of human proMMP-9/progelatinase B.
Boon L; Ugarte-Berzal E; Martens E; Vandooren J; Rybakin V; Colau D; Gordon-Alonso M; van der Bruggen P; Stöcker W; Becker-Pauly C; Witters P; Morava E; Jaeken J; Proost P; Opdenakker G
FEBS J; 2019 Mar; 286(5):930-945. PubMed ID: 30422384
[TBL] [Abstract][Full Text] [Related]
29. Fluorescence quenching studies of matrix metalloproteinases (MMPs): evidence for structural rearrangement of the proMMP-2/TIMP-2 complex upon mercurial activation.
Stack MS; Itoh Y; Young TN; Nagase H
Arch Biochem Biophys; 1996 Sep; 333(1):163-9. PubMed ID: 8806767
[TBL] [Abstract][Full Text] [Related]
30. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
[TBL] [Abstract][Full Text] [Related]
31. Effect of galardin on collagen degradation by Pseudomonas aeruginosa.
Hao JL; Nagano T; Nakamura M; Kumagai N; Mishima H; Nishida T
Exp Eye Res; 1999 Dec; 69(6):595-601. PubMed ID: 10620388
[TBL] [Abstract][Full Text] [Related]
32. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B.
Lees M; Taylor DJ; Woolley DE
Eur J Biochem; 1994 Jul; 223(1):171-7. PubMed ID: 8033891
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms for pro matrix metalloproteinase activation.
Murphy G; Stanton H; Cowell S; Butler G; Knäuper V; Atkinson S; Gavrilovic J
APMIS; 1999 Jan; 107(1):38-44. PubMed ID: 10190278
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures.
Fowlkes JL; Enghild JJ; Suzuki K; Nagase H
J Biol Chem; 1994 Oct; 269(41):25742-6. PubMed ID: 7523391
[TBL] [Abstract][Full Text] [Related]
35. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y
Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907
[TBL] [Abstract][Full Text] [Related]
36. Interaction between tissue inhibitor of metalloproteinases-2 and progelatinase A: immunoreactivity analyses.
Fujimoto N; Ward RV; Shinya T; Iwata K; Yamashita K; Hayakawa T
Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):827-33. PubMed ID: 8611162
[TBL] [Abstract][Full Text] [Related]
37. Comparative cleavage sites within the reactive-site loop of native and oxidized alpha1-proteinase inhibitor by selected bacterial proteinases.
Rapala-Kozik M; Potempa J; Nelson D; Kozik A; Travis J
Biol Chem; 1999 Oct; 380(10):1211-6. PubMed ID: 10595584
[TBL] [Abstract][Full Text] [Related]
38. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
39. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
Nie J; Pei D
Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471
[TBL] [Abstract][Full Text] [Related]
40. Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13.
Knäuper V; Bailey L; Worley JR; Soloway P; Patterson ML; Murphy G
FEBS Lett; 2002 Dec; 532(1-2):127-30. PubMed ID: 12459476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
